WallStSmart

Elevance Health Inc (ELV) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Elevance Health Inc stock (ELV) is currently trading at $291.48. Elevance Health Inc PE ratio is 11.56. Elevance Health Inc PS ratio (Price-to-Sales) is 0.32. Analyst consensus price target for ELV is $380.95. WallStSmart rates ELV as Moderate Buy.

  • ELV PE ratio analysis and historical PE chart
  • ELV PS ratio (Price-to-Sales) history and trend
  • ELV intrinsic value — DCF, Graham Number, EPV models
  • ELV stock price prediction 2025 2026 2027 2028 2029 2030
  • ELV fair value vs current price
  • ELV insider transactions and insider buying
  • Is ELV undervalued or overvalued?
  • Elevance Health Inc financial analysis — revenue, earnings, cash flow
  • ELV Piotroski F-Score and Altman Z-Score
  • ELV analyst price target and Smart Rating
ELV

Elevance Health Inc

NYSEHEALTHCARE
$291.48
$0.33 (0.11%)
52W$269.17
$449.16
Target$380.95+30.7%

📊 No data available

Try selecting a different time range

IV

ELV Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · Elevance Health Inc (ELV)

Margin of Safety
+75.3%
Strong Buy Zone
ELV Fair Value
$1179.83
Graham Formula
Current Price
$291.48
$888.35 below fair value
Undervalued
Fair: $1179.83
Overvalued
Price $291.48
Graham IV $1179.83
Analyst $380.95

ELV trades at a significant discount to its Graham intrinsic value of $1179.83, offering a 75% margin of safety — a level value investors typically seek before buying.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

Elevance Health Inc (ELV) · 10 metrics scored

Smart Score

67
out of 100
Grade: B-
Strong Buy
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in market cap, peg ratio, price/sales. Concerns around operating margin and profit margin. Overall metrics suggest strong investment potential with favorable risk/reward.

Elevance Health Inc (ELV) Key Strengths (6)

Avg Score: 9.2/10
Price/SalesValuation
0.3210/10

Paying less than $1 for every $1 of annual revenue

EPS GrowthGrowth
36.30%10/10

Earnings per share surging 36.30% year-over-year

Institutional Own.Quality
93.71%10/10

93.71% of shares held by major funds and institutions

Market CapQuality
$64.33B9/10

Large-cap company with substantial market presence

PEG RatioValuation
1.178/10

Good growth relative to its price

Price/BookValuation
1.478/10

Trading at 1.47x book value, attractively priced

Supporting Valuation Data

P/E Ratio
11.56
Undervalued
Forward P/E
11.39
Attractive
Trailing P/E
11.56
Undervalued
Price/Sales (TTM)
0.323
Undervalued
EV/Revenue
0.436
Undervalued
ELV Target Price
$380.95
15% Upside

Elevance Health Inc (ELV) Areas to Watch (4)

Avg Score: 3.0/10
Operating MarginProfitability
1.54%1/10

Near-zero operating margins, business under pressure

Profit MarginProfitability
2.84%2/10

Very thin margins, barely profitable

Revenue GrowthGrowth
9.50%4/10

Modest revenue growth at 9.50%

Return on EquityProfitability
13.30%5/10

Moderate profitability with room for improvement

Elevance Health Inc (ELV) Detailed Analysis Report

Overall Assessment

This company scores 67/100 in our Smart Analysis, earning a B- grade. Out of 10 metrics analyzed, 6 register as strengths (avg 9.2/10) while 4 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Sales, EPS Growth, Institutional Own.. Valuation metrics including PEG Ratio (1.17), Price/Sales (0.32), Price/Book (1.47) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 36.30%.

The Bear Case

The primary concerns are Operating Margin, Profit Margin, Revenue Growth. Growth concerns include Revenue Growth at 9.50%, which may limit upside. Profitability pressure is visible in Return on Equity at 13.30%, Operating Margin at 1.54%, Profit Margin at 2.84%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 13.30% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 9.50% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Mixed fundamentals with both positives (Price/Sales, EPS Growth) and negatives (Operating Margin, Profit Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

Compare ELV with Competitors

Top HEALTHCARE PLANS stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Elevance Health Inc (ELV) · HEALTHCAREHEALTHCARE PLANS

The Big Picture

Elevance Health Inc is a mature, profitable business with steady cash generation. Revenue reached 199.1B with 10% growth year-over-year. Profit margins are strong at 284.0%, reflecting pricing power and operational efficiency.

Key Findings

Excellent Capital Efficiency

ROE of 1330.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.

Strong Profitability

Profit margin of 284.0% and operating margin of 154.0% demonstrate strong pricing power and operational efficiency.

Negative Free Cash Flow

Free cash flow is -209M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.

What to Watch Next

Sector dynamics: monitor HEALTHCARE PLANS industry trends, competitive moves, and regulatory changes that could impact Elevance Health Inc.

Bottom Line

Elevance Health Inc is a well-established business delivering consistent profitability with 284.0% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Elevance Health Inc(ELV)

Exchange

NYSE

Sector

HEALTHCARE

Industry

HEALTHCARE PLANS

Country

USA

Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.